Zobrazeno 1 - 10
of 531
pro vyhledávání: '"JH Griffin"'
Autor:
Asztalos, Katherine J.1,2 (AUTHOR) kasztalos@anl.gov, Almashjary, Abdulrahman2 (AUTHOR), Dawson, Scott T. M.2 (AUTHOR)
Publikováno v:
Theoretical & Computational Fluid Dynamics. Dec2024, Vol. 38 Issue 6, p801-823. 23p.
Autor:
Das, Raja1 (AUTHOR) rdas3@ncsu.edu, Tien, Pham Van2 (AUTHOR), Wegmann, Karl W.1,3 (AUTHOR), Chakraborty, Madhumita4 (AUTHOR)
Publikováno v:
PLoS ONE. 10/25/2024, Vol. 19 Issue 10, p1-21. 21p.
Autor:
A Gruber, JH Griffin
Publikováno v:
Blood. 79:2340-2348
The antithrombotic enzyme, activated protein C (APC) was measured in blood using an enzyme capture assay (ECA). The ECA involved (1) collection of blood into anticoagulant containing a reversible inhibitor of the enzyme, (2) specific affinity capture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80c040ae38a8bdbe377f7ed181b1af19
https://doi.org/10.1182/blood.v79.9.2340.2340
https://doi.org/10.1182/blood.v79.9.2340.2340
Publikováno v:
Europe PubMed Central
Three dimensional homology models for the C1 and C2 domains of factor VIII (FVIII) were generated. Each C domain formed a beta-sandwich, and C1 was covalently connected to C2 in a head-to-head orientation. Of the250 missense mutations that cause FVII
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0407f853d08be4f6cd3925501a0e63ac
https://pubmed.ncbi.nlm.nih.gov/10669159
https://pubmed.ncbi.nlm.nih.gov/10669159
Publikováno v:
Europe PubMed Central
An important risk factor for thrombosis is the polymorphism R506Q in factor V that causes resistance of factor Va to proteolytic inactivation by activated protein C (APC). To study the potential influence of the carbohydrate moieties of factor Va on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::876dd58c7f5bd373a7900921e7994f35
https://pubmed.ncbi.nlm.nih.gov/9192757
https://pubmed.ncbi.nlm.nih.gov/9192757
Autor:
Martine Aiach, JH Griffin, Brigitte Jude, Martine Alhenc-Gelas, JF Abgrall, JS Greengard, Sophie Gandrille, Irène Juhan-Vague
Publikováno v:
Blood. 86(1)
Because multiple risk factors in one patient may increase the clinical expression of thrombophilia, we assessed the presence in protein C- deficient patients of the factor V Arg 506 Gln mutation responsible for activated protein C resistance. Using a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becabca70a0f1fefe828a98191bef7e4
https://pubmed.ncbi.nlm.nih.gov/7795227
https://pubmed.ncbi.nlm.nih.gov/7795227
Publikováno v:
Blood. 79(12)
The levels of total, free, and bound protein S and C4BP were determined using enzyme-linked immunosorbent assays (ELISAs) in plasma samples (8 males and 8 females) that were individually subjected to immunoadsorption studies in which “free protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd9c4c56fe76917ae63ae1489ae8385
https://pubmed.ncbi.nlm.nih.gov/1534488
https://pubmed.ncbi.nlm.nih.gov/1534488
Publikováno v:
Blood. 77(8)
In vivo complex formation of activated protein C with protein C inhibitor (APC-PCI) and with alpha 1-antitrypsin (APC-alpha 1AT) following infusion of 0.25 or 1.0 mg APC/kg in 1 hour into baboons was studied using immunoblotting and sandwich enzyme-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76525b180489a446b8705d978973ca54
https://pubmed.ncbi.nlm.nih.gov/1849759
https://pubmed.ncbi.nlm.nih.gov/1849759
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2017 Jul; Vol. 37 (7), pp. 1270-1271.
Autor:
Elsheikh, Mazen1 Mazenmoussa@med.asu.edu.eg, Akanbi, Lekan2, Selby, Lisbeth3, Ismail, Bahaaeldeen3
Publikováno v:
Journal of Neurogastroenterology & Motility. Apr2024, Vol. 30 Issue 2, p156-165. 10p.